On Thursday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: Vascular Biogenics Ltd. (NASDAQ:VBLT), Agnico Eagle Mines Limited (NYSE:AEM), Winnebago Industries, Inc. (NYSE:WGO), Staples, Inc. (NASDAQ:SPLS)
Vascular Biogenics Ltd. (NASDAQ:VBLT), with shares declined -16.62%, closed at $6.02.
Agnico Eagle Mines Limited (NYSE:AEM), with shares dropped -3.22%, settled at $29.14.
Winnebago Industries, Inc. (NYSE:WGO), with shares dipped -14.29%, and closed at $20.39.
Staples, Inc. (NASDAQ:SPLS), plummeted -3.17%, and closed at $16.02.
Latest NEWS regarding these Stocks are depicted underneath:
Vascular Biogenics Ltd. (NASDAQ:VBLT)
Vascular Biogenics Ltd. (VBLT), declared top-line interim results from its ongoing Phase 2 study of VB-111 in patients with recurrent glioblastoma (rGBM), which demonstrated a statistically noteworthy improvement in overall survival in patients treated with VB-111 followed by VB-111 in combination with bevacizumab (Avastin(R)) upon disease progression, contrast to patients treated with VB-111 followed by bevacizumab alone upon disease progression (p=0.05). Study results will be presented in conjunction with the American Society of Cancer Oncology (ASCO) Annual Meeting, May 29th-June 2nd, 2015 in Chicago, Illinois.
These interim Phase 2 data comprise 46 patients with rGBM. VB-111 monotherapy was suspended upon progression in 22 patients who were then treated with bevacizumab alone. The remaining 24 patients, upon disease progression on VB-111 monotherapy, could elect to receive further treatment with VB-111 in combination with bevacizumab. 23 have received combined therapy; one patient is still stable on VB-111 monotherapy at 424 days. VB-111 in combination with bevacizumab demonstrated a statistically noteworthy improvement in overall survival, with median overall survival of 414 days, contrast to 235 days in patients on VB-111 followed by bevacizumab alone (p=0.05).
VBL’s pivotal Phase 3 clinical trial will be led by Dr. Timothy Cloughesy, MD, Professor of Clinical Neurology and Director of the Neuro-Oncology Program, UCLA School of Medicine and is predictable to initiate in mid-2015 under a special protocol assessment granted by the FDA.
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical corporation, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates comprise VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, in addition to VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis.
Agnico Eagle Mines Limited (NYSE:AEM)
Agnico Eagle Mines Limited (AEM), declared that it has made several senior administration appointments and that it will release its first quarter 2015 results on Thursday, April 30, 2015, after normal trading hours. Additionally, the Corporation will host its Annual General Meeting the following day, Friday, May 1, 2015, in Toronto.
Senior Administration Appointments:
Agnico Eagle’s Board of Directors is happy to declare that Ammar Al-Joundi will be joining the Corporation as President, effective April 6, 2015. Mr. Al-Joundi was most recently Chief Financial Officer and Senior Executive Vice-President of Barrick Gold Corporation (from July 2012 to February 2015) and preceding to that was Chief Financial Officer of Agnico Eagle (from September 2010 to June 2012).
Preceding to joining Agnico Eagle in 2010, he spent 11 years at Barrick in various senior financial roles counting Senior Vice-President of Finance, Senior Vice-President of Business Strategy and Capital Allocation, and two years as Executive Director and CFO of Barrick South America. He is a graduate of the Ivey Business School (M.B.A.) at the University of Western Ontario, and has his undergraduate degree in Mechanical Engineering from the University of Toronto.
In his role as President, Mr. Al-Joundi will report to CEO Sean Boyd and assist him and the senior administration team in setting and executing on Agnico Eagle’s corporate strategy, optimizing the corporate structure and administration processes, developing the next generation of senior administration and building asset value through effective capital allocation and risk administration.
Agnico Eagle Mines Limited is engaged in the exploration, development, and production of mineral properties in Canada, Finland, and Mexico. It primarily explores for gold, in addition to for silver, copper, zinc, and lead.
Winnebago Industries, Inc. (NYSE:WGO)
Winnebago Industries, Inc. (WGO), stated financial results for the Corporation’s second quarter of Fiscal 2015 ended February 28, 2015.
Quarterly Cash Dividend:
The Corporation’s board of directors approved a quarterly cash dividend of $0.09 per share payable on May 6, 2015, to ordinary stockholders of record at the close of business on April 22, 2015.
Winnebago Industries, Inc. manufactures and sells recreation vehicles primarily for use in leisure travel and outdoor recreation activities. The corporation manufactures motor homes, which are self-propelled mobile dwellings that provide living accommodations and comprise kitchen, dining, sleeping, and bath areas, in addition to a lounge.
Staples, Inc. (NASDAQ:SPLS)
Staples, Inc. (SPLS), Canada is making more 3D printing happen by offering the latest 3D products and services in this rapidly growing area. The Afinia H-Series H480 3D Printer is now accessible on staples.ca and in 10 stores across British Columbia and Alberta.
Afinia 3D printers assist customers print sculptures, toys, prototypes, and components with convenience and precision. The Afinia 3D printer provides a true “out of the box” printing experience, ready to be used almost as soon as it’s unpacked.
Staples also stocks essential 3D printing accessories, such as ABS filaments, replacement nozzles, perf boards, and printing surface sheets.
A leading 3D printing retailer, Staples also carries an expanded assortment of 3D printing brands online and has seen a growth in the demand for 3D printing technology.
To showcase the revolutionary technology, Staples Canada will be giving away one Afinia 3D printer on social media. From March 27-March 30, step-by-step images of a 3D printed item will be revealed, with customers being asked to guess what’s being printed via Facebook, Twitter and Instagram for a chance to win. The winner will be revealed on March 31.
Staples, Inc., together with its auxiliaries, operates office products superstores. It operates through three segments: North American Stores & Online, North American Commercial, and International Operations. The corporation offers a range of office supplies, business technology products and services, facility and breakroom supplies, computers and mobility products, and office furniture under the Staples, Quill, and other proprietary brands.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
